|
|
1001 Aviation Pkwy, Suite 400 Morrisville, NC 27560 USA phone:919.466.9810 fax:919.466.9811
|
|
| Symbol |
Private |
| Founded |
2005 |
| Employees |
31 |
|
|
| www.ncontactsurgical.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| New tissue coagulation devices for surgical procedures. |
 |
| Management |
| John P. Funkhouser, President and CEO; James G. Whayne, Vice-President, Research and Clinicals; Sidney D. Fleischman, Vice-President, Development and Operations; Edgar Rey, Vice-President, Sales and Marketing; Nathalie Greene, Vice-President, Finance; Jane Ricupero, Vice-President, Regulatory and Quality Assurance; Jagruti Vyas, Director of Clinical Studies |
| |
|
|
| |
|
| Keywords |
| tissue coagulation, minimally invasive procedure |
|
|
|
| Description |
|
nContact is a medical device company founded in 2005 with a mission to develop devices for the endoscopic
treatment of arrhythmias, including atrial fibrillation (AF). The Numeris Coagulation System with VisiTrax is
based on the unique integration of suction, perfusion, and RF energy to ensure the creation of visible, nonconductive,
continuous, bi-atrial lesions on the epicardium of a beating heart. |
 |
| Products / Services |
To date, the Numeris Coagulation System with VisiTrax is indicated for endoscopic coagulation of cardiac
tissue in the United States. nContact has initiated IDE clinical studies for the treatment of AF in both open
and closed chest procedures. The Numeris Coagulation System with VisiTrax has CE Mark approval in
Europe for the coagulation of cardiac tissue for the treatment of AF and atrial flutter.
|
 |
 |
|
|
|
|
|
|